These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Lim SS; Jung SH; Ji J; Shin KH; Keum SR J Pharm Pharmacol; 2001 May; 53(5):653-68. PubMed ID: 11370705 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts. Varma SD; Kinoshita JH Biochem Pharmacol; 1976 Nov; 25(22):2505-13. PubMed ID: 825129 [No Abstract] [Full Text] [Related]
6. [Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens]. Tanimoto T; Fukuda H; Kawamura J Yakugaku Zasshi; 1984 Jun; 104(6):631-4. PubMed ID: 6438300 [No Abstract] [Full Text] [Related]
7. Determination of aldose reductase activity in the eye by localized magnetic resonance spectroscopy. Lizak MJ; Mori K; Kador PF J Ocul Pharmacol Ther; 2001 Oct; 17(5):475-83. PubMed ID: 11765152 [TBL] [Abstract][Full Text] [Related]
8. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats. Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425 [TBL] [Abstract][Full Text] [Related]
9. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens. Gonzalez AM; Sochor M; Hothersall JS; McLean P Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302 [TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway. Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572 [TBL] [Abstract][Full Text] [Related]
13. Lens aldose reductase in diabetic and galactosemic cataracts. Parmar NS; Ghosh MN Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119 [No Abstract] [Full Text] [Related]
14. The effect of aldose reductase and its inhibition on sugar cataract formation. Kador PF; Akagi Y; Kinoshita JH Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204 [TBL] [Abstract][Full Text] [Related]
15. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes. Ahmad SS; Tsou KC; Ahmad SI; Rahman MA Ophthalmic Res; 1985; 17(1):12-20. PubMed ID: 2984623 [TBL] [Abstract][Full Text] [Related]
16. Reaction and inhibition mechanisms of aldose reductase from rabbit lens. Tanimoto T; Fukuda H; Yamaha T; Tanaka C Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4183-9. PubMed ID: 3103935 [No Abstract] [Full Text] [Related]
17. A new approach against sugar cataract through aldose reductase inhibitors. Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473 [TBL] [Abstract][Full Text] [Related]
18. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. Iwu MM; Igboko OA; Okunji CO; Tempesta MS J Pharm Pharmacol; 1990 Apr; 42(4):290-2. PubMed ID: 1974302 [TBL] [Abstract][Full Text] [Related]
19. Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Matsuda H; Morikawa T; Toguchida I; Yoshikawa M Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):788-95. PubMed ID: 12045333 [TBL] [Abstract][Full Text] [Related]
20. Characterization of aldose reductases Ia and Ib from rabbit lens. Tanimoto T; Fukuda H; Kawamura J Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1025-31. PubMed ID: 6430575 [No Abstract] [Full Text] [Related] [Next] [New Search]